AesRx's Debt - III Round

AesRx raised a round of funding on December 10, 2013. Investors include Fletcher Spaght Ventures.

Aesrx is a biopharmaceutical company developing drugs to target sickle cell disease and inflammatory diseases of the lower intestine, including distal ulcerative colitis, pouchitis and radiation induc…

Articles about AesRx's Debt - III Round: